Another positive development for Lilly's weight-loss portfolio, with the company reporting positive results from its Phase 3 trial of a once-daily oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist. …
Lilly records another win in weight loss in trial of oral GLP-1 agonist
April 22, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Pharmac proposes three-monthly quantities for popular asthma inhalers
April 22, 2025 - - Latest News -
Lilly records another win in weight loss in trial of oral GLP-1 agonist
April 22, 2025 - - Latest News -
Australia increasingly isolated after Europe approves Alzheimer's therapy
April 22, 2025 - - BioPharma -
FDA removes industry representatives from its advisory committees
April 22, 2025 - - Latest News -
'Arguing over the proverbial lifejacket whilst patients are in the water drowning. Shame'
April 22, 2025 - - Latest News -
A mixed bag for the industry in Trump executive order on medicine pricing
April 17, 2025 - - Latest News -
Telix says IPAX-Linz study shows promising efficacy for glioma therapy candidate
April 16, 2025 - - Australian Biotech